Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice.

@article{Brown2018HypertensiveDO,
  title={Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice.},
  author={Mark A. Brown and Laura Ann Magee and Louise C. Kenny and S Ananth Karumanchi and Fergus P. McCarthy and Shigeru Saito and David Hall and Charlotte E. Warren and Gloria Adoyi and Salisu Ishaku},
  journal={Hypertension},
  year={2018},
  volume={72 1},
  pages={
          24-43
        }
}
These recommendations from the International Society for the Study of Hypertension in Pregnancy (ISSHP) are based on available literature and expert opinion. It is intended that this be a living document, to be updated when needed as more research becomes available to influence good clinical practice. Unfortunately, there is a relative lack of high-quality randomized trials in the field of hypertension in pregnancy compared with studies in essential hypertension outside of pregnancy, and ISSHP… 

Figures from this paper

Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement
Hypertensive disorders of pregnancy increase the risk of adverse maternal and fetal outcomes. In 2018, the Japanese classification of hypertensive disorders of pregnancy was standardized with those
Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines
TLDR
There are differences among international HDP guidelines related to dose and timing of aspirin initiation, thresholds for antihypertensive medication initiation, and BP targets, however, all guidelines acknowledge the significant morbidity associated with HDP and advocate for timely diagnosis and management to reduce associated morbidity and mortality.
Pharmacotherapy for hypertension in pregnant patients: special considerations
TLDR
Although there is a consensus that severe hypertension should be treated, treatment of mild hypertension without end-organ damage remains controversial and there is no agreement on when to initiate therapy, blood pressure targets or recommended drugs in the absence of robust evidence for the superiority of one drug over others.
Hypertensive disorders in pregnancy: 2019 National guideline.
TLDR
A clinical guideline that is of practical value has been formulated by a wide group of stakeholders and it is hoped that its dissemination and implementation by all doctors and nurses will reduce mortality and morbidity associated with HDP.
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
TLDR
There is emerging evidence that reducing blood pressure treatment goals in pregnancy may reduce maternal severe hypertension without increasing the risk of pregnancy loss, high-level neonatal care, or overall maternal complications.
Updates in the Prevention of Preeclampsia, What’s Beyond Aspirin?
  • A. Gabra
  • Medicine
    World Journal of Gynecology & Womens Health
  • 2020
TLDR
Examination of 21 pregnant women with an Antiphospholipid who experienced preeclampsia intrauterine growth during low-dose aspirin (LDA) molecular weight Low dose the control shows that Pravastatin reduced sFlt-1 and the production of soluble endoglin and decreased endothelial dysfunction in primary human tissues.
Updates in Management of Hypertensive Disorders of Pregnancy
  • A. Gabra
  • Medicine
    World Journal of Gynecology & Womens Health
  • 2019
TLDR
Recent updates and guidelines about the treatment of HDP are reviewed to help refine questions that may need to be answered by further studies and provide references for your further readings.
Hypertensive disorders of pregnancy and risk of asthma in offspring: protocol for a systematic review and meta-analysis
TLDR
The aim of this systematic review will be to summarise the available evidence examining the association between HDP and the risk of asthma in offspring, and to investigate whether HDP affects the severity of Asthma in exposed offspring and whether possible differences in therisk of asthma among different HDP subgroups exist.
...
...

References

SHOWING 1-10 OF 130 REFERENCES
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.
  • M. Martel
  • Medicine
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
  • 2008
Hypertensive Disorders of Pregnancy: A Systematic Review of International Clinical Practice Guidelines
TLDR
Existing international HDP CPGs have areas of consistency with which clinicians and researchers can work to develop auditable standards, and areas of inconsistency that should be addressed by future research.
Interpreting Abnormal Proteinuria in Pregnancy: The Need for a More Pathophysiological Approach
TLDR
If clinicians and investigators looked atproteinuria in terms of how the kidney handles protein in health and disease it would lead to a more rational and evidence-based approach to proteinuria in pregnancy, and current cutoff for abnormal proteinuria should be used to diagnose preeclampsia.
Post-Control of Hypertension in Pregnancy Study (CHIPS): What Is the Optimal Strategy to Manage Hypertension During Pregnancy?
TLDR
The Control of Hypertension in Pregnancy Study (CHIPS) was a multicenter randomized, controlled trial of BP management in pregnancy, designed to evaluate what the authors described as tight control compared with less tight control.
Cardiovascular risk management after a hypertensive disorder of pregnancy.
TLDR
The purpose of this review is to identify current barriers and opportunities for cardiovascular risk management after a hypertensive disorder of pregnancy and to suggest a practical approach for risk management.
Strategy for Standardization of Preeclampsia Research Study Design
TLDR
A strategy for research to study preeclampsia is presented, which will allow discrimination of such possible subtypes and also allow comparison and perhaps combinations of findings in different studies by standardized data and biosample collection.
...
...